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Abstract It has been suggested that cellular proteins are in-
volved in hepatitis C virus (HCV) RNA replication. By using
the yeast two-hybrid system, we isolated seven cDNA clones
encoding proteins interacting with HCV RNA polymerase
(NS5B) from a human liver cDNA library. For one of these,
K-actinin, we con¢rmed the interaction by coimmunoprecipita-
tion, immuno£uorescent staining and confocal microscopic anal-
ysis. Experiments with deletion mutants showed that domains
NS5B8495, NS5B466478, and K-actinin621733 are responsible
for the interaction. Studies of the HCV subgenomic replicon
system with small interference RNA indicate that K-actinin is
essential for HCV RNA replication. Our results suggest K-ac-
tinin may be a component of the HCV replication complex.
4 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Hepatitis C virus (HCV) belongs to the family Flaviviridae,
which comprises three genera of enveloped positive-strand
RNA viruses. The 9.6 kb genome of HCV consists of a
long open reading frame £anked by 5P and 3P non-translated
regions (NTRs) [1,2]. The HCV 5P NTR, 341 nucleotides in
length, functions as an internal ribosome entry site for cap-
independent translation initiation. The HCV polyprotein is
cleaved co- and post-translationally into at least 10 individual
polypeptides with the following gene order: 5P-C-E1-E2-p7-
NS2-NS3-NS4A-NS4B-NS5A-NS5B-3P [1^4]. The structural
proteins result from signal peptidase cleavages in the N-ter-
minal portion of the polyprotein. Two viral proteases mediate
downstream cleavages to produce non-structural proteins that
function as components of the HCV RNA replicase. The
NS2^3 protease spans the C-terminal half of NS2 and the
N-terminal one-third of NS3 and catalyzes autocatalytic cis-
cleavage at the two-thirds site. This same portion of NS3 also
encodes the catalytic domain of the NS3^4A serine protease
that cleaves at four downstream sites. The C-terminal two-
thirds of NS3 is highly conserved among HCV isolates, with
RNA-binding, RNA-stimulated NTPase and RNA-unwinding
activities. Although NS4B and the NS5A phosphoprotein are
also likely components of the replicase, their speci¢c roles are
unknown. The C-terminal polyprotein cleavage product,
NS5B, is the elongation subunit of the HCV replicase possess-
ing RNA-dependent RNA polymerase (RdRp) activity [5].
Following a translation stop codon, the HCV 3P NTR consists
of three subregions: (i) a 28^42-base sequence that varies
among genotypes, (ii) an internal poly(U/UC) tract of variable
length with rare A or G residues, and (iii) a highly conserved
3P terminal 98-base sequence [6]. It is generally believed that
conserved sequences and structures at the 3P terminus of viral
genomic RNA function as cis-acting signals that interact with
viral and cellular proteins to initiate the synthesis of minus-
strand RNA during viral replication.
The NS5B protein of HCV is a membrane-associated phos-
phoprotein that possesses the conserved GDD motif of
RdRps [2]. NS5B RdRp activity has been demonstrated in
vitro, and several amino acid motifs essential for its enzymatic
activity have been identi¢ed [6]. It seemed likely that initiation
of minus-strand RNA synthesis might be upon recognition
and speci¢c binding of the NS5B RNA polymerase or repli-
cative complex to the 3P terminus of the viral genomic RNA
[7]. However, recent studies have indicated that HCV NS5B
interacts with the 3P conserved 98 nt of the viral genome with
little speci¢city [5,7] and no clear preference for utilization of
the 98-nt RNA as a template in RdRp activity assay [8^10].
Recently, NS5B was reported to bind to hVAP-33, a human
vesicle-associated membrane protein, and to complex with
NS3 and NS4A [11,12]. Although as yet untested, association
of NS5B with other non-structural proteins and cellular pro-
teins could be required to produce an RNA replicase with
speci¢city for HCV template RNA.
To uncover possible components of the HCV replication
complex, we employed the yeast two-hybrid system and a
human hepatocyte cDNA library to search for cellular pro-
teins that interact with HCV NS5B. K-Actinin, a member of a
superfamily of actin cross-linking proteins, was among seven
interactors identi¢ed. K-Actinin interacts with actin subdo-
main 2 and part of subdomain 1. We con¢rmed protein^pro-
tein interaction between NS5B and K-actinin by coimmuno-
precipitation, immuno£uorescent staining and confocal
microscopy. The interaction domains of NS5B and K-actinin
were mapped by deletion mutant analysis. Studies with the
HCV subgenomic replicon system indicate K-actinin is essen-
tial for HCV RNA replication. These data suggest that
K-actinin may be a component of the HCV RNA replication
machinery.
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2. Materials and methods
2.1. Plasmids
For the yeast two-hybrid system, the plasmids pLexA and pB42AD
(Clontech) were used as sources of the LexA DNA-binding domain
and LexA transcriptional activation domain (AD), respectively. To
generate the bait plasmids (pLexA-NS5B and pLexA-NS5Bv21),
pLexA was inserted with the BamHI fragment from the prokaryotic
expression vector pET32c-NS5B or pET32c-NS5Bv21, which express
the full-length or truncated HCV NS5B protein (without the C-termi-
nal 21 amino acids to ensure translocation to the nucleus). A human
liver cDNA library cloned into pB42AD was obtained from Clontech.
The plasmid pcDNA3/HA-actinin was constructed by insertion of the
EcoRI-XhoI fragment of plasmid pB42AD-actinin. The plasmid
pCMV/HA-actinin, encoding K-actinin and a hemagglutinin (HA) epi-
tope tag at the N-terminus, was also derived from pB42AD-actinin.
To generate a myc epitope-tagged NS5B protein, mammalian re-
combinant vector pcDNA3.1/myc-HisB-NS5B was constructed by in-
serting the BamHI-XhoI fragment of plasmid pET28a-NS5B into vec-
tor pcDNA3.1/myc-HisB excised by the same two enzymes. The NS5B
fragment excised from expression vector pET32c-NS5B by BamHI
digestion was inserted into pEGFPC2 to generate pEGFPC2-NS5B
that encodes the green £uorescent protein (GFP)-NS5B fusion pro-
tein. Deletion mutants of NS5B and K-actinin were generated by poly-
merase chain reaction (PCR) and then cloned into pLexA and
pB42AD plasmids.
2.2. Two-hybrid screening
The yeast reporter strain EGY48 [p8op-lacZ] obtained from Clon-
tech was used for the two-hybrid selection. Either plasmid pLexA-
NS5B or pLexA-NS5Bv21 was used as bait. The pB42AD cDNA
library (Clontech) from human liver was used as the source of prey
genes. Yeast cells were grown on YPD (1% yeast extract, 2% peptone,
2% dextrose, 2% agar [for plates]) or on synthetic minimal medium
(0.67% yeast nitrogen base, the appropriate auxotrophic supplements,
2% agar [for plates]) containing 2% dextrose or 2% galactose and 1%
ra⁄nose. Yeast was transformed with appropriate plasmids by the
lithium acetate method. The transformants were selected on the ap-
propriate synthetic minimal medium. The bait plasmid and the
pB42AD cDNA library were introduced into the yeast strain
EGY48 [p8op-lacZ]. The two-hybrid screen and interaction assays
were performed essentially as described in the protocol (Clontech)
in the presence of 2% galactose and 80 mg of 5-bromo-4-chloro-3-
indolyl-D-galactopyranoside per liter. The prey plasmids were selected
from yeast colonies giving a positive signal according to the manu-
facturer’s protocol. False positives were eliminated by retransforming
the host EGY48 [p8op-lacZ] strain with pB42AD-cDNA plus bait
plasmid or pLexA control plasmid. The positive clones that contained
cDNAs encoding NS5B-interacting proteins were sequenced and sub-
jected to BLAST analysis.
2.3. Coimmunoprecipitation
For in vitro coimmunoprecipitation, plasmids pcDNA3/HA-actinin
and pcDNA3.1/myc-HisB-NS5B were used. [35S]Methionine-labeled
HA-actinin and NS5B-myc were translated in vitro using the TNT
Quick Coupled Transcription/Translation System (Promega). HA-ac-
tinin and NS5B-myc were incubated with monoclonal anti-HA anti-
body or anti-myc antibody in lysis bu¡er (50 mM Tris^HCl pH 7.5,
150 mM NaCl, 1 mM EDTA, 0.1% NP-40, 1 mM phenylmethylsul-
fonyl £uoride), followed by adsorption to bovine serum albumin-
blocked protein A/G-agarose (Boehringer Mannheim). The beads
were washed thrice with lysis bu¡er (50 mM Tris^HCl pH 7.5, 150
mM NaCl, 1 mM EDTA, 0.1% NP-40). The antibody^protein com-
plexes were then resolved in 10% sodium dodecyl sulfate^polyacryl-
amide gel electrophoresis (SDS^PAGE) and subjected to autoradiog-
raphy.
For in vivo coimmunoprecipitation, 1U107 Huh-7 cells containing
HCV replicons were washed three times with ice-cold phosphate-bu¡-
ered saline (PBS) and solubilized with 1 ml lysis bu¡er (50 mM Tris^
HCl pH 7.5, 150 mM NaCl, 0.5% NP-40, 5 mM EDTA, 5 mM
EGTA, 15 mM MgCl2, 60 mM L-glycerophosphate, 0.1 mM sodium
orthovanadate, 0.1 mM NaF, 1 mM phenylmethylsulfonyl £uoride,
1Uproteinase inhibitor cocktail [Roche]). Detergent-insoluble materi-
als were removed by centrifugation at 15 000Ug for 10 min at 4‡C.
The whole cell lysates were incubated with monoclonal antibody
(mAb) against K-actinin (Santa Cruz, sc-17829) or mouse normal
IgG at 4‡C for 2 h. Pre-equilibrated protein G-agarose beads were
then added, and after 2 h of incubation, they were collected by cen-
trifugation and then gently washed three times with the lysis bu¡er.
The bound proteins were eluted by boiling in SDS sample bu¡er and
resolved on a 10% SDS^PAGE gel. The proteins were transferred
onto a polyvinylidene di£uoride membrane and probed with a poly-
clonal antibody against HCV NS5B (Santa Cruz, sc-17532). Proteins
were detected using 3,3P,5,5P-tetramethylbenzidine (TMB) substrate.
2.4. Indirect immuno£uorescence and confocal microscopic analysis
COS7 cells seeded in six-well chamber slides were transfected
with plasmids pCMV/HA-actinin and either pEGFPC2-NS5B or
pEGFPC2 (5 Wg) by the calcium phosphate method. At 48 h post
transfection, the cells were ¢xed with 2% formaldehyde in PBS. Per-
meabilization of the cells was carried out with 0.2% Triton X-100 in
PBS containing 1% fetal calf serum. Samples were then incubated with
mouse anti-HA mAb (Babco) at 4‡C overnight. After being washed
thrice with PBS containing 1% fetal calf serum, samples were incuba-
ted at 37‡C for 1 h with a second antibody, rhodamine-conjugated
anti-mouse immunoglobulin. After further washing, coverslips were
¢nally mounted on glass plates and cells were observed by confocal
laser scanning microscope (Leica, TCS-NT, Heidelberg, Germany)
2.5. Generation of stable HCV subgenomic replicon cell line
The BB7 HCV subgenomic replicon (genotype 1b) was obtained
from Charles Rice (The Rockefeller University, New York, NY,
USA). Huh-7 cells were transfected with HCV subgenomic replicon
RNA and maintained as described by Blight et al. [13]. Huh-7 clone R
cells harboring autonomously replicating HCV replicon RNA were
used in related experiments.
2.6. Construction of plasmid expressing interfering RNA targeting on
K-actinin
According to the small interference RNA (siRNA) ¢nder (Ambion,
http://www.ambion.com/techlib/misc/siRNA_¢nder.html), the K-acti-
nin-targeting sequence 5P-TCGCATCTGCAAGGTGTTG-3P was se-
lected. Sense and antisense strands of siRNA oligonucleotides against
K-actinin RNA were synthesized and were then annealed at 95‡C for
1 min followed by slow cooling in PBS, pH 6.8, containing 2 mM
MgCl2. They were inserted immediately downstream of the U6 pro-
moter in pSilence1.0 U6 siRNA Expression vector (Ambion). Control
plasmid pSi-EGFP, which can produce siRNAs targeting EGFP
RNA, was constructed similarly. Transfections of the plasmids were
performed in six-well plates using Fugen6 (Roche) in accordance with
the manufacturer’s instructions. 2 Wg plasmid was transfected in each
well.
2.7. RNA analysis
Total cellular RNA was isolated using TRIZOL reagent (Invitro-
gen) according to the manufacturer’s protocol. After treatment with
DNase I, one-tenth of each RNA sample from a 36-mm well was
reverse-transcribed with random primers (dN6) by Superscript II (In-
vitrogen). Real-time PCR (LightCycler, Roche) ampli¢cations were
performed using the CYBR I reagents (Roche) according to the man-
ufacturer’s protocol. Cellular glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) mRNA from the same cell lysate was used as an
internal control for cell number and metabolic status. The primers
speci¢c for the HCV 5P NTR are: 5P-CCCTGTGAGGAACTA/
TCTGTCTTCACGC-3P (sense), 5P-TCCAGAGCATCTGGCACG-
TA/GGTACTCG-3P (antisense). The primers speci¢c for GAPDH
are: 5P-GGTATCGTGGAAGGACTCATGAC-3P (sense), 5P-ATGC-
CAGTGAGCTTCCCGTTCAGC-3P (antisense). Forty cycles of PCR
were performed with cycling conditions of 15 s at 95‡C, 20 s at 55‡C,
25 s at 72‡C. The real-time PCR signals were analyzed using Light-
Cycler 3 software. Each experiment was repeated at least three times.
3. Results
3.1. Identi¢cation of cellular proteins interacting with HCV
NS5B
To identify cellular proteins interacting with HCV NS5B,
the LexA yeast two-hybrid system was employed to screen a
human liver cDNA library (MATCHMAKER cDNA library
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from Clontech). We screened the hepatocellular cDNA library
with full-length NS5B protein and obtained 24 candidates;
after cotransformation to eliminate false positive phenotypes,
none were retained (data not shown). However, when using
the truncated HCV NS5B protein (lacking the C-terminal 21
amino acids) as bait, 43 clones were detected as positive can-
didates during the ¢rst round screening of 2U106 independent
yeast colonies and seven clones remained consistently positive
after rigorous testing. The cDNA clones were sequenced and
subjected to BLAST analysis. As supported by NCBI data-
base (USA), the following genes showed 100% homology to
identi¢ed cDNA clones: K-actinin, protease 26S subunit, pro-
teasome subunit L4, HeLa cyclin-dependent kinase 2 interact-
ing protein and tetratricopeptide repeat protein 4 as well as
hydroxyacid oxidase 1.
3.2. Coimmunoprecipitation of NS5B with K-actinin
For in vitro coimmunoprecipitation, tagged proteins HA-K-
actinin and NS5B-myc were translated in vitro using the TNT
Quick Coupled Transcription/Translation System in the pres-
ence of [35S]methionine. Radiolabeled HA-actinin and NS5B-
myc were incubated with an anti-HA mAb and immune com-
plexes were captured on protein A/G-agarose. The antibody^
protein complexes were then resolved in 10% SDS^PAGE and
subjected to autoradiography. NS5B-myc was coimmunopre-
cipitated with HA-K-actinin by the anti-HA antibody (Fig.
1A, lane 3). In contrast, NS5B-myc was not precipitated by
the anti-HA antibody when HA-K-actinin was absent from
the reaction mix (Fig. 1A, lane 4). Similarly, HA-K-actinin
could be coimmunoprecipitated with NS5B-myc by the anti-
myc antibody (Fig. 1A, lane 5) and it was not immunopreci-
pitated by the anti-myc antibody when NS5B-myc was absent
from the reaction mix (Fig. 1A, lane 6). These results indi-
cated that NS5B interacted with K-actinin in vitro.
For in vivo coimmunoprecipitation, lysates of Huh-7 cells
harboring HCV replicons were incubated with mAb against
K-actinin. The antibody^protein complexes were probed with
a polyclonal antibody against HCV NS5B. Results showed
that NS5B could be precipitated from Huh-7 HCV replicon
cells with antibody against K-actinin (Fig. 1B, lane 3) but not
by mouse normal serum (Fig. 1B, lane 4). No NS5B could be
detected from Huh-7 cells by immunoprecipitation with mAb
against K-actinin (Fig. 1B, lane 2). These results indicated that
endogenous K-actinin could interact with NS5B in Huh-7 cells
harboring HCV replicons.
3.3. NS5B colocalizes with K-actinin
In COS7 cells transiently transfected with plasmids pCMV/
HA-actinin and pEGFPC2-NS5B, NS5B was found to colo-
calize with K-actinin by confocal laser scanning microscopy
(Fig. 2A). As a negative control, COS7 cells were cotrans-
fected with plasmids pCMV/HA-actinin and pEGFPC2. Re-
sults showed that K-actinin and EGFP were distributed inde-
pendently and K-actinin was distributed in the whole cell
when GFP alone was overexpressed, and the GFP signals
were spread di¡usely in both the nucleus and cytoplasm
(Fig. 2B). However, GFP-NS5B was exclusively distributed
in the cytoplasm and K-actinin was redistributed to the cyto-
plasm when coexpressed with GFP-NS5B protein (Fig. 2A).
These results indicated that the binding of K-actinin to NS5B
resulted in a change in distribution of K-actinin. The strong
cytoplasmic distribution of K-actinin in the NS5B-expressing
cells indicates the binding of K-actinin to NS5B may play an
important role in NS5B function and HCV RNA replication.
3.4. Mapping the interacting domains of NS5B and K-actinin
To examine the regions of HCV NS5B protein and K-acti-
nin responsible for their binding to each other, a series of
deletion mutants were constructed (Fig. 3) and the interac-
tions were assayed using the yeast two-hybrid system. The
results showed that mutants NS5B196, NS5B83150 and
NS5B428478 could interact with K-actinin while NS5B183,
NS5B96150 and NS5B377465 could not. So the interaction
for HCV NS5B on K-actinin maps to two independent do-
mains: aa 84^95 and aa 466^478. For K-actinin, the C-termi-
nal fragments aa 499^892 and aa 621^892 could interact with
NS5Bv21. Further deletion from aa 621 to aa 733 abolished
the NS5B interaction. Therefore the minimum region neces-
sary for binding NS5B is within aa 621^733, which harbors
spectrin domain 4.
3.5. K-Actinin is essential for HCV RNA replication
The direct binding of K-actinin and NS5B may a¡ect the
synthesis of HCV RNA. To test this hypothesis, we undertook
siRNA strategy in the recently developed HCV subgenomic
Fig. 1. A: In vitro coimmunoprecipitation of NS5B with K-actinin.
Tagged proteins HA-K-actinin and NS5B-myc were translated in vi-
tro with [35S]methionine incorporation (lanes 1 and 2). After HA-K-
actinin and NS5B-myc were immunoprecipitated with monoclonal
anti-HA antibody or anti-myc antibody, the antibody^protein com-
plexes were resolved in 10% SDS^PAGE and subjected to autora-
diography. NS5B-myc was coimmunoprecipitated with HA-K-actinin
by the anti-HA antibody (lane 3) and it was not immunoprecipi-
tated by the anti-HA antibody when HA-K-actinin was absent from
the reaction mix (lane 4). Similarly, HA-K-actinin was coimmuno-
precipitated with NS5B-myc by the anti-myc antibody (lane 5) and
it was not immunoprecipitated by the anti-myc antibody when
NS5B-myc was absent from the reaction mix (lane 6). B: In vivo
coimmunoprecipitation of NS5B. Lysates of Huh-7 cells harboring
HCV replicons were incubated with an mAb against K-actinin. The
antibody^protein complexes were probed with a polyclonal antibody
against HCV NS5B. Proteins were detected using TMB substrate.
Lane 1, input of the lysate of Huh-7 cells harboring HCV replicons
without immunoprecipitation; lane 2, immunoprecipitation of lysate
of Huh-7 cells with mAb against K-actinin; lane 3, immunoprecipi-
tation of lysate of Huh-7 cells harboring HCV replicons with mAb
against K-actinin; lane 4, immunoprecipitation of lysate of Huh-7
cells harboring HCV replicons with mouse normal sera.
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replicon system. RNA interference was used to reduce intra-
cellular K-actinin expression. To determine whether siRNA
speci¢c to K-actinin could inhibit the expression of K-actinin
in cells, Western blot analysis was performed. Compared with
mock-transfected cells, the K-actinin level declined to 37% in
cells transfected with plasmid pSi-Act (Fig. 4), while trans-
fection of plasmid pcDNA3/HA-actinin resulted in the over-
expression of K-actinin. HCV RNA quantitative analysis re-
vealed that the HCV RNA levels in subgenomic replicon cells
decreased signi¢cantly after transfection with plasmid pSi-Act,
which produced siRNA against K-actinin RNA (P6 0.05),
but were not a¡ected by control plasmid pSi-EGFP, which
produced siRNAs unrelated to the K-actinin or HCV RNA
sequence (Fig. 5). These data indicate that K-actinin may be a
component of the HCV replication complex and play a role in
the replication of the subgenomic replicon via the interaction
with NS5B.
4. Discussion
HCV replication consists of minus-strand RNA replication
and plus-strand RNA replication and has been regarded as a
target for intervention to block chronic infection. Both pro-
cesses seem to happen at membranous structures where non-
structural proteins dynamically assemble as a replication com-
plex with HCV RNA. Recently it was proposed that NS5B
RdRp activity could be regulated at the level of protein^pro-
tein interactions, homomeric oligomerization and heteromeric
interaction between NS5B and NS5A [14^16].
Here, using the yeast two-hybrid system, we identi¢ed seven
cellular proteins that interact with HCV NS5B. The interac-
tion between NS5B and K-actinin was further con¢rmed by an
in vitro coimmunoprecipitation assay and by immuno£uores-
cent staining and confocal microscopy. Two independent do-
mains of NS5B, aa 84^95 and aa 466^478, and domain 621^
733 of K-actinin are responsible for the interaction (Fig. 3).
Primary functional study showed that K-actinin could modu-
late NS5B activity. Our study suggests that K-actinin (and
perhaps other cellular proteins) may be involved in control
of HCV RNA replication.
We ¢rst used full-length NS5B for two-hybrid screening.
With this bait, no positive clones were obtained. These neg-
ative results may have resulted from the amphipathic helix at
the C-terminus of NS5B. Mammalian expression studies sug-
gest that this 21-residue hydrophobic segment serves as a
membrane anchor [17]. Deletion of this domain during Esche-
richia coli expression facilitates NS5B solubility and was an
important step towards determining the crystal structure of
this enzyme [8]. In the LexA yeast two-hybrid system, reporter
genes are e⁄ciently activated when both fusion proteins can
be imported into the nucleus. Consistent with this idea, dele-
tion of the carboxy-terminal 21 aa leads to nuclear redistribu-
tion of NS5B [17]. Use of this carboxy-terminally truncated
NS5B protein as bait yielded seven positive cDNA clones. It
Fig. 2. NS5B was colocalized with K-actinin in COS7 cells. COS7 cells on coverslips were transfected with plasmids pCMV/HA-actinin and ei-
ther pEGFPC2-NS5B or pEGFPC2. At 48 h post transfection, the cells were ¢xed and immunostained with mouse anti-HA monoclonal anti-
body and rhodamine-conjugated anti-mouse immunoglobulin. Coverslips were ¢nally mounted on glass plates and cells were observed in a con-
focal laser scanning microscope (Leica, TCS-NT, Heidelberg, Germany). Images recorded in red (rhodamine) and green (GFP) channels are
presented separately on the left and on the right, respectively, and composite images are shown in the middle. (For interpretation of the refer-
ences to color in this ¢gure legend, the reader is referred to the web version of this article.)
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should be noted, however, that full-length NS5B was used in
subsequent experiments to con¢rm protein^protein interac-
tions.
Formation of a membrane-associated replication complex is
a characteristic feature of positive-strand RNA viruses [18].
The non-structural proteins of dengue virus, Japanese ence-
phalitis virus and HCV (NS3 to NS5B) are able to assemble
into membrane-associated replication complexes, competent
for authentic RNA genome replication [19,20]. Although the
determinants of membrane association are beginning to be
de¢ned [17], protein^protein interactions involved in forma-
tion of the HCV replicase are poorly understood. Regarding a
possible role of K-actinin in formation and/or function of the
HCV replicase, host cytoskeletal proteins have been impli-
cated in HCV and other viral systems. It has been demon-
strated that microtubule and actin polymerization were re-
quired for HCV RNA synthesis in the HCV replicon cell
culture system [21]. For the paramyxoviruses, measles virus
and Sendai virus, mRNA synthesis is stimulated in vitro by
tubulin, the major structural component of microtubules, and
inhibited by anti-L-tubulin antibodies [22^24]. mRNA synthe-
sis of human parain£uenza virus type 3 and respiratory syn-
cytial virus requires cellular actin, a major component of mi-
cro¢laments in the host cytoskeletal network [25,26]. Actin
and tubulin might serve as anchoring sites on the cytoskeleton
for viral RNA polymerase. Assembling the RNA polymerase
on the cytoskeleton or on cell membranes may ensure appro-
priate concentrations of replication components and hence
control the rates or e⁄ciencies of replication reactions.
K-Actinin is a member of a superfamily of actin cross-link-
ing proteins and interacts with actin subdomain 2 and a part
of subdomain 1 through its 27-kDa actin-binding domain [27].
While the NS5B-binding site on K-actinin maps to the C-ter-
minus, the N-terminus of K-actinin is responsible for binding
to actin. So NS5B may interact with actin through K-actinin.
It has been reported that NS5B can be oligomerized which is a
prerequisite for RdRp activity and the residues E18 in the
long loop and H502 in the thick thumb are critical for oligo-
merization [14]. As E18 and H502 are located in the vicinity
of the two independent domains which are essential for
K-actinin binding NS5B, there is a possibility that, like nucle-
olin [28], actinin may a¡ect the oligomerization of NS5B.
Furthermore, the two binding domains of NS5B, aa 84^95
and aa 466^478, are located in the regions that surround the
template strand according to structure analysis [29]. So the
RdRp activity of NS5B could possibly be a¡ected by the
interaction with K-actinin. This ¢nding may lead to the eluci-
dation of the detailed protein^protein interactions and their
involvement in formation of the membrane-associated repli-
cation complex and may provide new insights into fundamen-
Fig. 3. Schematic representation of the amino- or carboxy-terminally
truncated NS5B and K-actinin proteins used for the two-hybrid sys-
tem assay to map the interaction domain. The open columns indi-
cate NS5B and its deletion mutants and the closed ones indicate
K-actinin and its deletion mutants. The numbers on the left of col-
umns indicate the amino acid sites. The results of the yeast two-hy-
brid assay are summarized on the right.
Fig. 4. Inhibition of K-actinin expression by siRNA. Western blot
analysis was performed on total cell lysates harvested from mock-,
pSi-Act-, or pcDNA3/HA-actinin-transfected replicon-bearing cells
at 48 h post transfection using K-actinin-speci¢c or actin-speci¢c
antibodies. Molecular mass markers (in kDa) are shown on the
right of each gel. Densitometry readings (as percentages of the
mock-transfected control) for lanes 1^3 were 100, 37 and 931, re-
spectively, for K-actinin, 100, 99 and 106 for actin.
Fig. 5. E¡ects of siRNA targeting K-actinin on HCV RNA replica-
tion in HCV subgenomic replicon cells. In a six-well plate, Huh-7
cells harboring HCV replicons were transfected with 2 Wg plasmid
pSi-Act or pSi-EGFP. At 48 h post transfection the cells were har-
vested for RNA extraction. Real-time PCR ampli¢cations were per-
formed after reverse transcription. The signals were analyzed using
Light-Cycler 3 software. The levels of HCV replicon RNA, after
normalization against GAPDH, are shown as percentages of the
mock-transfected control. Representative data (meanVS.D.) from
three independent experiments are shown. Asterisk indicates P6
0.05.
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tal cellular processes and identify novel targets for antiviral
intervention.
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